These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1761364)

  • 1. Clinical benefits and recovery of delayed-type hypersensitivity in patients with AIDS-related complex treated with IMREG-1 or placebo.
    Fiala M; Cone LA; Sayre JW
    Int J Immunopharmacol; 1991; 13(7):999-1004. PubMed ID: 1761364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial.
    Gottlieb MS; Zackin RA; Fiala M; Henry DH; Marcel AJ; Combs KL; Vieira J; Liebman HA; Cone LA; Hillman KS
    Ann Intern Med; 1991 Jul; 115(2):84-91. PubMed ID: 1676251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunologic observations in patients with AIDS-related complex treated with IMREG-1.
    Gottlieb AA
    Int J Immunopharmacol; 1991; 13 Suppl 1():29-32. PubMed ID: 1823905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of immunomodulators for treatment of HIV infection.
    Gottlieb AA; Gottlieb MS
    Lymphology; 1990 Jun; 23(2):98-101. PubMed ID: 2214868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by IMREG-1: a measure of the immunopotentiation of cell-mediated immunity.
    Sizemore RC; Kern CH; Gottlieb MS; Gottlieb AA
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):308-13. PubMed ID: 7554453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    Fischl MA; Richman DD; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D; Schooley RT
    N Engl J Med; 1987 Jul; 317(4):185-91. PubMed ID: 3299089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of immune function in AIDS/ARC.
    Gottlieb AA; Gottlieb MS; Scholes VE
    Concepts Immunopathol; 1987; 4():261-74. PubMed ID: 2954644
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Moye J; Bethel J; Hirschhorn R; Jordan C; Nugent R
    JAMA; 1992 Jul 22-29; 268(4):483-8. PubMed ID: 1352363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
    Cooper DA; Pehrson PO; Pedersen C; Moroni M; Oksenhendler E; Rozenbaum W; Clumeck N; Faber V; Stille W; Hirschel B
    AIDS; 1993 Feb; 7(2):197-207. PubMed ID: 8096703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group.
    Cooper DA; Pedersen C; Aiuti F; Vilde JL; Ruhnke M; Pehrson PO; Clumeck N; Farthing C; Lüthy R; Doherty RR
    AIDS; 1991 Aug; 5(8):933-43. PubMed ID: 1777174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
    AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
    Stambuk D; Hawkins D; Gazzard BG
    J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
    Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
    Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
    Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
    Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prevention of Pneumocystis carinii pneumonia by pentamidine inhalation].
    Jablonowski H; Elsing C; Erckenbrecht J; Hengels KH; Strohmeyer G
    Dtsch Med Wochenschr; 1992 Jul; 117(31-32):1181-4. PubMed ID: 1353721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDS.
    Hirschel B; Chopard P; Chave JP; Furrer HJ; Opravil M; Hilti P; Vernazza P; Lazzarin A
    Med Klin (Munich); 1990 Apr; 85 Suppl 2():268-70. PubMed ID: 2197536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.
    Crumpacker C; Heagy W; Bubley G; Monroe JE; Finberg R; Hussey S; Schnipper L; Lucey D; Lee TH; McLane MF
    Ann Intern Med; 1987 Nov; 107(5):664-74. PubMed ID: 3662279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
    AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals.
    Ambrus JL; Poiesz BJ; Lillie MA; Stadler I; Di Berardino LA; Chadha KC
    Am J Med; 1989 Oct; 87(4):405-7. PubMed ID: 2478016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.